Assisted reproductive technology and ovarian cancer

Minerva Endocrinologica

Volumn 35, Issue 4, 2010, Pages 247-257

  Devesa, M ^a   Barri, P N ^a   Coroleu, B ^a  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

Fertility agents; Infertility; Ovarian neoplasms; Ovulation induction

Indexed keywords

CONTRACEPTIVE AGENT; GONADOTROPIN;

CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; INFERTILITY THERAPY; NULLIPARA; OVARY CANCER; OVULATION; REVIEW; SEXUAL INTERCOURSE;

CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; OVARIAN NEOPLASMS; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 79953068264     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Klip H, Burger CW, de Kraker J, van Leeuwen FE. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod 2001;16:2451-8. (Pubitemid 33054154)
2. FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2003;83 (Suppl 1): xx-xxii, 1-229.
3. Goodman M, Howe H. Descriptive epidemiology of ovarian cancer in the United States, 1992-1997. Cancer 2003;(Suppl):2615-30.
4. Edmonson RJ, Monaghan JM. The epidemiology of ovarian cancer. Int J Gynecol Cancer 2001;11:423-9.
5. Choi JH, Wong AST, Huang HF, Leung PCK. Gonadotropins and ovarian cancer. Endocrine Reviews 2007;28(4):440-61.
6. Elit L. Familial ovarian cancer. Can Fam Physician 2001;47:778-84.
7. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971;2:163.
8. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Nad Cancer Inst 1998;90:1774-86. (Pubitemid 28559889)
9. Artini PG, Fasciani A, Cela V, Battaglia C, A. De Micheroux A, D'Ambrogio G et al. Fertility drugs and ovarian cancer. Gynecol Endocrinol 1997, 11:59-68.
10. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JL, Strom BL et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994;139:654-61. (Pubitemid 24121274)
11. Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control 2000;11:319-44. (Pubitemid 30255874)
12. Brinton LA;Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE et al. Ovarian cancer risk after the use of ovulation stimulating drugs. Obstet Gynecol 2004;103:1194-203.
13. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6. (Pubitemid 24284766)
14. Tworoger SS, Fairfield KM, Colditz GA, Rosner BA, Hankinson SE. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol 2007;166:894-901.
15. Venn A, Watson L, Lumley J, Giles G, King G, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Risk of cancer after use of infertility drugs with in Vitro fertilization. Lancet 1995;346:995-1000.
16. Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long term follow up study. Fertil Steril 1999;71:853-9. (Pubitemid 29206910)
17. Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovivi T et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998;147:1038-42.
18. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586-90. (Pubitemid 29515949)
19. Jensen A, Sharif H, Olsen JH, Kjaer SK. Risk of breast and gynaecologic cancers in a large population of nearly 50000 infertile Danish women. Am J Epidemiol 2008;168:49-57. (Pubitemid 351881887)
20. Whittemore A, Harris S, Itnyre J. The collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:1184-203. (Pubitemid 23026890)
21. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mogaard BJ et al. Infertility, fertility drugs and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002;155:217-24. (Pubitemid 34117299)
22. Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG. A case-control study of ovarian cancer in relation to infertility and the use of ovulation - inducing drugs. Am J Epidemiol 2004;160:1070-8. (Pubitemid 39557459)
23. Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factor - a review. Placenta 2008;29:169-77.
24. Schildkraut JM, Schwingt PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996;88:554-9. (Pubitemid 26326017)
25. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie J et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 2004;82:405-14.
26. Melin A, Sparén P, Bergqvist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 2007;22:3021-6. (Pubitemid 351696799)
27. Brinton LA, Moghissi KS, Scoccia B, Westhoff CL, Lamb EJ. Ovulation induction and cancer risk. Fertil Steril 2005;83:261-74. (Pubitemid 40221776)
28. Doyle P, Maconochie N, Beral V. Cancer indicence following treatment for infertility at a clinic in the UK. Hum Reprod 2002;17:2209-13.
29. Klip H, Burger CW, Leeuwen Van, the Omega Project Group. Risk of hormone-related cancers after ovarian stimulation for in-vitro fertilization in a cohort of 25152 women. In: Klip H, editor. Long-term health effects of subfertility treatment. Enschede: PrintPartners Ipskamp BV; 2002. p. 55-82.
30. Calderon-Margalit R, Friedlander Y, Yanetz R, Kelinhaus K, Perrin MC, Manor O et al. Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 2009;169:365-75.
31. Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study. BMJ 2009;338:b249.
32. Dos Santos Silva I, Wark PA, McCormack VA, Mayer D, Overton C, Little V et al. Ovulation - stimulation drugs and cancer risks: a long-term follow-up of a British cohort. BJC 2009;100:1824-31.
33. Sanner K, Conner P, Bergfeldt K, Dickman P, Sundfeldt K, Bergh T et al. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril 2009;91:1152-8.
34. Sushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker J. Human menopausal gonadotrophin and the risk of epithelial ovarian cancer. Fertil Steril 1996;65:13-8. (Pubitemid 26006641)
35. Moosgard BJ, Lidegaard O, Kjaer SK, Schou G, Nyboe Andersen A. Infertility, fertility drugs and invasive ovarian cancer: a case-control study. Fertil Steril 1997;67:1005-11.
36. Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod 1997;12:2159-61.
37. Kashyap S, Moher D, Fung Kee Fung M, Rosenwaks Z. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis. Obstet Gynecol 2004;103:785-94. (Pubitemid 40459044)
38. Balasch J, Barri P. Follicular stimulation and ovarian cancer? Hum Reprod 1993;8:990-6.